feisty
A mid-contract equity top-up for a CEO looks, on the surface, like a retention play. The board grants additional long-term incentive (LTI) shares or options outside the normal cycle, the ASX announcement describes a desire to "align executive incentives with shareholder value," and most observers move on. What they miss is the subtext. The timing of a mid-cycle equity grant, the structure chosen, and the performance conditions attached tell you far more about a board's state of mind than the press release does.
Why boards reach for equity between cycles
Normal LTI cycles at ASX-listed companies run on an annual grant schedule. The board approves a quantum, the remuneration committee sets performance hurdles, and the CEO receives the award. A mid-contract top-up breaks that rhythm, and breaking rhythm costs the board something: scrutiny from proxy advisers, questions at the AGM, and the risk of looking like they're rewarding a CEO without proper justification.
Boards absorb that cost for three distinct reasons, and they're worth separating.
The first is genuine retention risk. If a CEO has received a credible approach from another company or private equity, the board may be reacting to real competitive pressure on the package. This is the scenario the press release always implies. It does happen, but it's the least common reason.
The second is underwater options. When the share price falls significantly after a CEO's LTI grant, the existing incentive plan loses its motivating function. A CEO holding options with a strike price well above the current market price has little financial reason to stay. The board can reset the plan by granting new awards at current prices, effectively preserving the retention mechanism without admitting the original targets were too optimistic. This happens more than investors realise.
The third reason is the riskiest to read: the board is trying to lock the CEO in place ahead of a transaction. A merger, a demerger, a major asset sale, or a capital raising that requires executive continuity for 18 to 24 months often prompts a retention grant structured specifically around that timeline. The CEO gets incremental equity; the board gets a committed operator for the period that matters.
What the structure of the grant reveals
The form of the top-up grant carries as much signal as the timing. Rights with a time-based vesting schedule, rather than performance hurdles, suggest the board's priority is continuity, not stretch performance. The message is: stay, and you get paid.
Performance rights with TSR hurdles attached say something different. The board is confident enough in the CEO's direction to add upside, not just lock them in. That's a vote of confidence dressed as a retention tool.
Grants with bespoke conditions, specific to a project milestone or a balance sheet target, are the clearest signal of the three. They tell the market that the board has tied the CEO's financial interest directly to a known event or outcome. You won't always know what that event is when the grant is announced. But it usually becomes clear within 18 months.
The quantum matters too. A top-up grant worth less than 30 percent of the CEO's annual LTI entitlement is a housekeeping move. A grant approaching 100 percent of that entitlement is a significant structural decision, and it warrants proportionate scrutiny.
What proxy advisers and institutional investors look for
Glass Lewis and ISS, the two proxy advisers whose recommendations carry weight at Australian AGMs, both apply heightened scrutiny to off-cycle equity grants. Their primary concern is whether the grant represents an inadvertent re-test of performance conditions. If a CEO failed to hit their first LTI tranche, a top-up grant at lower targets effectively forgives the miss. Both firms flag this in their voting recommendations, and a significant proportion of institutional holders will vote against the remuneration report if they see it.
This is the governance risk boards sometimes underestimate. The grant itself may be defensible. But if it's structured in a way that looks like it's papering over a performance miss, the AGM creates a public record of shareholder dissatisfaction. That's a reputational cost that persists past the vote.
Savvy remuneration committees pre-empt this by briefing major institutional holders before the ASX announcement. A major fund receiving a call from the chair or the remco chair a week before the release can ask questions privately and avoid a surprise at the AGM. Those that don't brief ahead of time often learn the hard way.
The signal investors should actually act on
Not every mid-cycle equity top-up is a warning sign. The ones worth pausing on share a specific profile: the grant comes within 12 months of an LTI tranche failing to vest, the performance conditions on the new grant are materially lower than those on the failed one, and no credible business rationale is offered for the timing beyond "retention."
That combination suggests a board that lacks the discipline to hold its own performance framework. A CEO who receives equity in that context has, in effect, had their accountability reset. That changes the incentive structure in ways that don't show up on a remuneration table.
Mid-cycle equity grants that follow a major capital event, a leadership change below the CEO, or a strategic pivot are different. As covered in the analysis of when the board changes its dividend policy mid-cycle, boards that adjust multiple settings at the same time are usually responding to a structural shift, not avoiding accountability. The equity grant in that context is part of a coherent repositioning, not a patch on a broken plan.
The board's willingness to disclose the reasoning in detail is the clearest indicator of intent. A remuneration committee chair who fronts the media, explains the grant in plain terms, and commits to a specific outcome is signalling confidence. One who releases a boilerplate ASX announcement and goes quiet is signalling something else.
What this means for the CEO's position
From the CEO's perspective, accepting a mid-contract top-up is not costless. It ties their financial outcome more tightly to the board's current agenda, and if that agenda shifts, the conditions may look very different in two years. A CEO who takes a large retention grant and then encounters a new chair or a hostile remuneration committee is in a complicated position.
This is why the nature of the relationship between the CEO and the board matters as much as the grant's headline value. The dynamics are similar to those explored in the analysis of when both the chair and CEO seats change simultaneously: when the principals are new to each other, the financial structures they build together carry more risk than they appear to on paper.
The equity top-up is a contract within a contract. It binds the CEO to the board's current priorities, at a moment when those priorities may already be under pressure. The terms that look attractive on the day of the grant can become the source of serious tension within 18 months. That's worth reading carefully, on both sides of the boardroom table.